Stay updated on Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.

Latest updates to the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s technical revision/version footer was updated from v3.5.2 to v3.5.3, indicating a tooling or publishing update rather than a change to the study record content.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. The visible study details appear unchanged in the current view.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check71 days agoChange DetectedUpdated the Study Record Dates with a new last update posted on 2026-02-24 and a new last update submitted on 2026-02-20. Older dates (e.g., 2025-01-08, 2025-01-06) were removed.SummaryDifference0.3%

- Check85 days agoChange DetectedThe page shows a minor version update from v3.4.1 to v3.4.2 with no visible changes to trial information or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.